SUPN icon

Supernus Pharmaceuticals
SUPN

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$64
30% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Piper Sandler
Piper Sandler
David Amsellem
100% 1-yr SUPN win rate
9 Oct ‘25 7 days ago
Cantor Fitzgerald
Cantor Fitzgerald
Kristen Kluska
100% 1-yr SUPN win rate
30 Sep ‘25 16 days ago